the choice simply comes down to your preferences regarding cost and administration style
Chemical analogues of GLP-1 are currently approved for the treatment of type 2 diabetes (T2D) and obesity 3,4
adults are now on GLP-1 medications, roughly double the rate from 18 months earlier (per KFF Health Tracking Poll, November 2025)
Women are more willing to tolerate injections for weight loss Women were more likely than men to say they would tolerate injections for weight loss despite disliking needles, at 11.23% compared to 7.94%
Protects against insulin resistance: It helps protect against age, diet, and obesity-dependent insulin resistance
While results take time, stabilizing hormone levels often leads to more consistent day-to-day performance, both mentally and physically